This inventor holds 1 USPTO granted patent. Top assignee: Immune-Path Biotechnology (Suzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chengren Shen: Innovator in Adjuvant Systems
Introduction
Chengren Shen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of adjuvant systems. His innovative work has the potential to enhance vaccine efficacy and improve public health outcomes.
Latest Patents
Chengren Shen holds a patent for a "Composite adjuvant system and method for preparing adjuvant." This patent presents a new adjuvant system that combines an aluminum phosphate adjuvant with a CpG adjuvant, along with the method for its preparation. This advancement is crucial for the development of more effective vaccines.
Career Highlights
Chengren Shen is currently employed at Immune-Path Biotechnology (Suzhou) Co., Ltd. His role at the company allows him to focus on innovative research and development in the biotechnology sector. His expertise and dedication have positioned him as a key figure in his field.
Collaborations
Chengren has collaborated with notable colleagues, including Li Shi and Zhi Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Chengren Shen's contributions to the field of biotechnology, particularly through his patent on adjuvant systems, highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile